--- title: "Weekly Recap | 1873.HK this week, a quiet rangebound week" type: "News" locale: "en" url: "https://longbridge.com/en/news/304714823.md" description: "Viva Biotech had no major catalysts this week. The latest quote stands at HK$1.335, with the day’s range between HK$1.280 and HK$1.355, a swing of about 5.8%. Turnover was 7.24 million shares for HK$9.59 million. The stock opened at HK$1.300 and closed flat against the previous close, showing a quiet, rangebound session typical of a mid-to-small cap name." datetime: "2026-11-07T05:42:31.000Z" locales: - [zh-CN](https://longbridge.com/zh-CN/news/304714823.md) - [en](https://longbridge.com/en/news/304714823.md) - [zh-HK](https://longbridge.com/zh-HK/news/304714823.md) generator: "portal-rs" --- # Weekly Recap | 1873.HK this week, a quiet rangebound week ## The Week Viva Biotech had no major catalysts this week. The latest quote stands at HK$1.335, with the day’s range between HK$1.280 and HK$1.355, a swing of about 5.8%. Turnover was 7.24 million shares for HK$9.59 million. The stock opened at HK$1.300 and closed flat against the previous close, showing a quiet, rangebound session typical of a mid-to-small cap name. ## Analyst Ratings One broker covers the stock, rating it buy with no hold, sell or underweight calls. The consensus is a strong buy, with a consensus target of HK$2.807, about 110.3% above the latest price of HK$1.335. The target range is a single point at HK$2.807, meaning no dispersion across estimates. Within the life science tools and services industry, the stock ranks 11th out of 12 names by analyst rating, placing it in the lower half. ## The Week Ahead Hong Kong unemployment data lands on Tuesday, 17 November, with a prior reading of 3.9%. CPI follows on Friday, 20 November, after a previous print of 1.9%. On the company side, Viva Biotech reports fiscal Q3 2026 results after the close on Thursday, 26 November, the most direct fundamental checkpoint ahead. One English-language item from 5 November noted Viva Biotech climbed 6% in Hong Kong trading, but that move is not reflected in the Chinese-language feed for this week. *This article is generated by LongbridgeAI from market data, for information only and not investment advice.* ### Related Stocks - [01873.HK](https://longbridge.com/en/quote/01873.HK.md) ## Related News & Research - [10:57 ETViva Biotech Announces Its 2026 Interim Results: AI Sparks New Paradigm in Drug R&D, CDMO Commercial Manufacturing Accelerates Revenue Growth](https://longbridge.com/en/news/297064309.md) - [Viva Biotech grants 6.22 million RSUs to CDMO staff at HK$ 1.08 each](https://longbridge.com/en/news/290927873.md) - [Tesla Cybercab’s ‘Autonomy Subscription’ covers all bases for a self-driving car](https://longbridge.com/en/news/306297563.md) - [Tesla proposes $3.1 bln Texas polysilicon plant for solar manufacturing](https://longbridge.com/en/news/306309064.md) - [Tesla expands Supercharger Waitlist to 300 sites across the U.S.](https://longbridge.com/en/news/306189672.md) --- > **Disclaimer: This article is for reference only and does not constitute any investment advice.**